Infection by influenza virus in childhood: A call for broader influenza vaccination;Infección por el virus influenza en la infancia. ¿Deberían ampliarse las indicaciones de la vacuna antigripal?

Archivos de Bronconeumologia

Volumn 40, Issue 5, 2004, Pages 231-235

  Escribano Montaner, A ^a,c   De Juanes Pardo, J R ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE;

CHILD CARE; CHILDHOOD DISEASE; HEALTH PROGRAM; HUMAN; INFANT; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; REVIEW;

EID: 2542502438     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13060348     Document Type: Review

References (56)

1. Glezen WP, Keitel WA, Taber LH, Piedra PA, Clower RD, Couch RB. Age distribution of patients with medically atended illnesses caused by sequencial variants of influenza A/H1N1: comparison to age specific infection rates, 1978-89. Am J Epidemiol 1991;133:296-304.
2. Frank A, Taber L, Wells C, Glezen WP, Paredes A. Patttern of shedding of mixoviruses and paramixoviruses in children. J Infect Dis 1981;144:433-41.
3. Longini JM, Koopman JS, Monto AS, Fox JP. Estimating household and community transmission parameters for influenza. Am J Epidemiol 1982;115:736-51.
4. Fox JP, Hall CE, Cooney MK, Foy HM. Influenza virus infection in Seattle families, 1975-1979. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol 1982;116:212-27.
5. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2002;51(RR-3):1-31.
6. Influenza. En: Peter G, editor. Red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village: American Academy of Pediatrics, 1997; p. 307-15.
7. Nicholson KG, Snacken R, Palache AM. Influenza immunization polices in Europe and the United States. Vaccine 1995;13:365-8.
8. Committee on Infectious Diseases 2002-2003. Recommended childhood and adolescent immunization schedule-United States, 2003. Pediatrics 2003;111:212.
9. Comité Asesor de Vacunas de la AEP. Calendario vacunal de la Asociación Española de Pediatría 2003. An Pediatr (Barc) 2003; 58:257-62.
10. LeVine AM, Koeningsknecht V, Stark JM. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods 2001;94:173-86.
11. Malhotra A, Krilov LR. Influenza and respiratory syncitial virus. Update on infection, management and prevention. Pediatr Clin North Am 2000;47:353-72.
12. Cox N, Subbarao K. Influenza. Lancet 1999;354:1277-82.
13. Glezen WP. Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections. Vaccine 2000;19(Suppl 1):56-8.
14. O'Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B, et al. Severe pneumococcal pneumonia in previosly healthy children: the role of preceding influenza infection. Clin Infect Dis 2000;30:784-9.
15. Mossad SB. Underused options for preventing and treating influenza. Cleveland Clin J Med 1999;66:19-23.
16. Glezen WP, Taber LH, FranK A, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr Infect Dis J 1997;16:1065-8.
17. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999;340:260-4.
18. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991;145:445-8.
19. Clemments DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med 1995;149:1113-7.
20. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccines in children. N Engl J Med 1998;338:1405-12.
21. Hekkinen T. The role of respiratory viruses in otitis media. Vaccine 2000;19(Suppl 1):51-5.
22. Eriksson M, Benet R, Nilsson A. Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy. Pediatr Allergy Immunol 2000;11:193-7.
23. Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000;137:856-64.
24. Kramarz P, De Stefano F, Gargiullo PM, Chen RT, Lieu TA, Davis El, et al. Vaccine Safetly Datalink Team. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001;138:306-10.
25. Dagan R, Hall CB. Influenza A virus infection imitating bacterial sepsis in early infancy. Pediatr Infect Dis 1984;3:218-21.
26. Kao HT, Huang YC, Lin TY. Influenza A virus infection in infants. J Microbiol Immunol Infect 2000;33:105-8.
27. Togashi T, Matsuzono Y, Narita M. Epidemiology of influenza-associated encephalitis-encephalopaty in Hokkaido, the northern-most island of Japan. Pediatr Int 2000;42:192-6.
28. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. An J Public Health 1997;87:1944-50.
29. Fisher RG, Gruber WC, Edwards KM, Reed GW, Tollefson SJ, Thomson JM, et al. Twenty years of outpatient respiratory syncitial virus infections a framework for vaccine efficacy trial. Pediatrics 1997;99:E7.
30. Couch RB, Kasel JA, Glezen WP, et al. Influenza: its control in persons and populations. J Infect Dis 1986;153:431-40.
31. Glezen WP, Paredes A, Taber LH. Influenza in children: relationship to other respiratory agents. JAMA 1980;243:1345-9.
32. Glezen WP. Considerations of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis 1980;2:408-20.
33. Mullooly JP, Barker WH. Impact of type A influenza in children: a retrospective study. Am J Public Health 1982;72:1008-16.
34. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342:225-31.
35. Hayden GF, Frayha H, Kattan H, Mogarri I. Structured guidelines for the use of influenza vaccine among children with chronic pulmonary disorders. Pediatr infect Dis J 1995;14:895-9.
36. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-9.
37. Sugaya N, Mitamura K, Nirasawa M, Takahashi K. The impact of winter epidemics of influenza and respiratory syncitial virus on paediatric admissions to an urban general hospital. J Med Virol 2000;60:102-6.
38. Monto AS, Davenport FM, Naiper JA, Francis T Jr. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970;122:16-25.
39. Reichert TA, Sugaya N, Fedson DS, Glezen P, Simonsen L, Tashiro M. The Japanesse experience with vaccinating schoolchildren against influenza. N Engl J Med 2001;344:889-96.
40. Tango T, Santomi H, Mori H, Yamaoka K. Efficacy of influenza vaccination-the detection of a seeming efficacy. Nippon Koshu Eisei 1990;37:967-78.
41. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. 5th ed. Atlanta: CDC, 1999; p. 247-64.
42. American Academy of Pediatrics. Recommended childhood and adolescent immunization schedule-United States, 2003. Pediatrics 2003; 111:212. Disponible en: http://www.aap.org/policy/0212.html
43. De Juanes JR, Arrazola MP. Vacunas inactivadas de la gripe. Vacunas: Investigación y Práctica 2002;3:47-50.
44. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendation of the Advisory Committee on Immunization Practice (ACIP). MMWR 2002;51(RR-03). Disponible en: http://www.cdc.gov/mmwr/preview/htm
45. Centers for Disease Control and Prevention. Questions and answers on influenza vaccine and Guillen-Barre syndrome (GBS). Disponible en: www.cdc.gov/nip/vacsafe/vaccinesafety/hottopics/gbs.htm
46. Reina J. Vacunas atenuadas (cold-adapted) de la gripe. Vacunas: Investigación y Práctica 2002;3:51-61.
47. Beyer WE, Palache AM, De Jong JC, Osterhaus AD. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 2002;20:1340-53.
48. Alenxandrova G, Smorodintsev A. Obtaining of an additionally attenuated vaccinating cryophilic influenza strain. Rev Roum Inframicrobiol 1965;2:179-89.
49. Rudenko L, Ramires A, Barro M. Vaccination properties of live recombinant influenza types A and B used separately and in combination in children of 3-14 years. Vorp Virusol 1991;36:474.
50. Rudenko L, Slepushkin A, Monto A. Efficacy of live attenuatedand inactivated influenza vaccine in schoolchildren and their unvaccinated contacts in Novgorod. Rusia. J Infect Dis 1993;168:881-7.
51. Maasab HF. Plaque formation of influenza virus at 25 °C. Nature 1968;219:645-6.
52. Maasab HF, Deborde DC. Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine 1985;3:355-69.
53. Ruiz Contreras J. Vacuna intranasal frente a la gripe. En: Campins M, Moraga FA, editores. Vacunas 2001. Barcelona: Proust Science, 2001; p. 173-9.
54. Belshe RB, Gruber WG, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent intranasal influenza virus vaccine. J Infect Dis 2000;181:1133-7.
55. FDA. First nasal mist flu vaccine approved. FDA News, 2003, 17 June. Disponible en: www.fda.gov/bbs/topics/NEWS/2003/NEW00913.html
56. Murphy BR, Nelson DL, Wryght PF, Tiemey EL, Phelan MA, Chanock RM. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infecc Immun 1982;36:1102-8.